Try our Advanced Search for more refined results

Expert Analysis

Value-Based Challenges And Opportunities For Pharma Cos.

By Eve Brunts and Alison Fethke (July 12, 2017, 1:29 PM EDT) -- Value-based health care and the high cost of drugs have both received significant attention in the ongoing debate on the future of health care. Value-based pricing for drugs may offer pharmaceutical companies an opportunity to validate the cost of their drugs and overcome obstacles to access. Over the past couple of years, pharmaceutical companies and private health plans have announced new value-based pricing arrangements linking the cost of drugs to their perceived value, receiving widespread media coverage....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!